Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid homeostasis (GO:0055089) | 7.39691146 |
2 | estrogen biosynthetic process (GO:0006703) | 6.89989086 |
3 | diacylglycerol metabolic process (GO:0046339) | 6.30091869 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.24541100 |
5 | L-phenylalanine catabolic process (GO:0006559) | 6.24541100 |
6 | progesterone metabolic process (GO:0042448) | 6.06887804 |
7 | androgen biosynthetic process (GO:0006702) | 6.06821275 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.04835173 |
9 | L-phenylalanine metabolic process (GO:0006558) | 6.04835173 |
10 | triglyceride biosynthetic process (GO:0019432) | 6.02017765 |
11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.93032371 |
12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.92409389 |
13 | response to phenylpropanoid (GO:0080184) | 5.78724297 |
14 | neutral lipid biosynthetic process (GO:0046460) | 5.74879460 |
15 | acylglycerol biosynthetic process (GO:0046463) | 5.74879460 |
16 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 5.51226898 |
17 | glucocorticoid biosynthetic process (GO:0006704) | 5.45312753 |
18 | aromatic amino acid family catabolic process (GO:0009074) | 5.42165135 |
19 | complement activation, alternative pathway (GO:0006957) | 5.29569659 |
20 | white fat cell differentiation (GO:0050872) | 5.28500117 |
21 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.25262274 |
22 | glycerolipid catabolic process (GO:0046503) | 5.24048079 |
23 | * brown fat cell differentiation (GO:0050873) | 5.19083503 |
24 | glyoxylate metabolic process (GO:0046487) | 5.16217676 |
25 | NADH metabolic process (GO:0006734) | 5.14929140 |
26 | bile acid biosynthetic process (GO:0006699) | 5.10082582 |
27 | regulation of triglyceride catabolic process (GO:0010896) | 5.08357412 |
28 | sulfur amino acid catabolic process (GO:0000098) | 5.06862411 |
29 | cysteine metabolic process (GO:0006534) | 4.96346157 |
30 | lipid particle organization (GO:0034389) | 4.89901858 |
31 | plasma lipoprotein particle clearance (GO:0034381) | 4.89653118 |
32 | lipid storage (GO:0019915) | 4.88678126 |
33 | acylglycerol homeostasis (GO:0055090) | 4.87241131 |
34 | triglyceride homeostasis (GO:0070328) | 4.87241131 |
35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86739942 |
36 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.86734595 |
37 | low-density lipoprotein particle clearance (GO:0034383) | 4.84885089 |
38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.81694477 |
39 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.81391395 |
40 | urea cycle (GO:0000050) | 4.73042071 |
41 | urea metabolic process (GO:0019627) | 4.73042071 |
42 | tryptophan catabolic process (GO:0006569) | 4.72616361 |
43 | indole-containing compound catabolic process (GO:0042436) | 4.72616361 |
44 | indolalkylamine catabolic process (GO:0046218) | 4.72616361 |
45 | cellular response to epinephrine stimulus (GO:0071872) | 4.72560601 |
46 | regulation of sequestering of triglyceride (GO:0010889) | 4.70928839 |
47 | kynurenine metabolic process (GO:0070189) | 4.67909045 |
48 | C21-steroid hormone biosynthetic process (GO:0006700) | 4.66294869 |
49 | regulation of protein activation cascade (GO:2000257) | 4.59577812 |
50 | acyl-CoA metabolic process (GO:0006637) | 4.56465481 |
51 | thioester metabolic process (GO:0035383) | 4.56465481 |
52 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.54384863 |
53 | negative regulation of fibrinolysis (GO:0051918) | 4.53346259 |
54 | triglyceride catabolic process (GO:0019433) | 4.49783192 |
55 | valine metabolic process (GO:0006573) | 4.49465284 |
56 | cellular response to cadmium ion (GO:0071276) | 4.49243627 |
57 | positive regulation of lipid storage (GO:0010884) | 4.46521217 |
58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.44849713 |
59 | protein carboxylation (GO:0018214) | 4.44849713 |
60 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.44499201 |
61 | retinol metabolic process (GO:0042572) | 4.44273603 |
62 | tryptophan metabolic process (GO:0006568) | 4.43485409 |
63 | C21-steroid hormone metabolic process (GO:0008207) | 4.42923691 |
64 | bile acid metabolic process (GO:0008206) | 4.39536529 |
65 | acylglycerol catabolic process (GO:0046464) | 4.38718224 |
66 | neutral lipid catabolic process (GO:0046461) | 4.38718224 |
67 | nitrogen cycle metabolic process (GO:0071941) | 4.38669021 |
68 | lysine catabolic process (GO:0006554) | 4.38606463 |
69 | lysine metabolic process (GO:0006553) | 4.38606463 |
70 | fatty acid beta-oxidation (GO:0006635) | 4.35362216 |
71 | response to follicle-stimulating hormone (GO:0032354) | 4.35005412 |
72 | acylglycerol metabolic process (GO:0006639) | 4.34838407 |
73 | regulation of complement activation (GO:0030449) | 4.32702540 |
74 | plasma lipoprotein particle remodeling (GO:0034369) | 4.32317557 |
75 | protein-lipid complex remodeling (GO:0034368) | 4.32317557 |
76 | macromolecular complex remodeling (GO:0034367) | 4.32317557 |
77 | reverse cholesterol transport (GO:0043691) | 4.29677095 |
78 | acetyl-CoA metabolic process (GO:0006084) | 4.29586584 |
79 | regulation of fibrinolysis (GO:0051917) | 4.29078020 |
80 | neutral lipid metabolic process (GO:0006638) | 4.28820259 |
81 | serine family amino acid catabolic process (GO:0009071) | 4.28362034 |
82 | amino-acid betaine metabolic process (GO:0006577) | 4.28238792 |
83 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.24952116 |
84 | positive regulation of lipid catabolic process (GO:0050996) | 4.24705511 |
85 | primary alcohol metabolic process (GO:0034308) | 4.24397086 |
86 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.22533310 |
87 | negative regulation of macrophage differentiation (GO:0045650) | 4.21065689 |
88 | positive regulation of glomerulus development (GO:0090193) | 4.20106043 |
89 | fatty acid oxidation (GO:0019395) | 4.19138959 |
90 | positive regulation of fatty acid oxidation (GO:0046321) | 4.15965135 |
91 | glucocorticoid metabolic process (GO:0008211) | 4.15354495 |
92 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.14248145 |
93 | lipid oxidation (GO:0034440) | 4.10793494 |
94 | homocysteine metabolic process (GO:0050667) | 4.05307396 |
95 | response to epinephrine (GO:0071871) | 4.04980297 |
96 | tyrosine metabolic process (GO:0006570) | 4.03902476 |
97 | regulation of cholesterol esterification (GO:0010872) | 4.03550519 |
98 | fatty acid catabolic process (GO:0009062) | 4.02117051 |
99 | biotin metabolic process (GO:0006768) | 3.99526741 |
100 | alpha-amino acid catabolic process (GO:1901606) | 3.96603106 |
101 | fatty acid transmembrane transport (GO:1902001) | 3.96046466 |
102 | ethanol oxidation (GO:0006069) | 3.93049917 |
103 | aromatic amino acid family metabolic process (GO:0009072) | 3.92322738 |
104 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.91891477 |
105 | phospholipid efflux (GO:0033700) | 3.90206452 |
106 | negative regulation of lipase activity (GO:0060192) | 3.89804631 |
107 | 2-oxoglutarate metabolic process (GO:0006103) | 3.85582367 |
108 | short-chain fatty acid metabolic process (GO:0046459) | 3.84383650 |
109 | glycerol metabolic process (GO:0006071) | 3.82900757 |
110 | tricarboxylic acid metabolic process (GO:0072350) | 3.82336138 |
111 | cellular ketone body metabolic process (GO:0046950) | 3.82086630 |
112 | monocarboxylic acid catabolic process (GO:0072329) | 3.79465356 |
113 | branched-chain amino acid catabolic process (GO:0009083) | 3.79369478 |
114 | oxaloacetate metabolic process (GO:0006107) | 3.78911305 |
115 | positive regulation of cholesterol efflux (GO:0010875) | 3.78183976 |
116 | epoxygenase P450 pathway (GO:0019373) | 3.74809512 |
117 | cellular amino acid catabolic process (GO:0009063) | 3.74469958 |
118 | coenzyme catabolic process (GO:0009109) | 3.74081312 |
119 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.74059402 |
120 | benzene-containing compound metabolic process (GO:0042537) | 3.72234959 |
121 | cellular response to lithium ion (GO:0071285) | 3.68027754 |
122 | transcytosis (GO:0045056) | 3.66697661 |
123 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.65648459 |
124 | cellular response to antibiotic (GO:0071236) | 3.64978205 |
125 | cholesterol efflux (GO:0033344) | 3.63841541 |
126 | organic acid catabolic process (GO:0016054) | 3.59770896 |
127 | carboxylic acid catabolic process (GO:0046395) | 3.59770896 |
128 | plasma lipoprotein particle assembly (GO:0034377) | 3.59378894 |
129 | branched-chain amino acid metabolic process (GO:0009081) | 3.58224483 |
130 | phospholipid homeostasis (GO:0055091) | 3.58222186 |
131 | regulation of triglyceride metabolic process (GO:0090207) | 3.56579244 |
132 | phosphatidic acid biosynthetic process (GO:0006654) | 3.55577385 |
133 | phosphatidic acid metabolic process (GO:0046473) | 3.55577385 |
134 | Leydig cell differentiation (GO:0033327) | 3.55414542 |
135 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.55311102 |
136 | protein heterotrimerization (GO:0070208) | 3.55074429 |
137 | regulation of cholesterol storage (GO:0010885) | 3.54557919 |
138 | intracellular lipid transport (GO:0032365) | 3.54554002 |
139 | carnitine metabolic process (GO:0009437) | 3.54090847 |
140 | cholesterol homeostasis (GO:0042632) | 3.53326573 |
141 | negative regulation of cholesterol transport (GO:0032375) | 3.52833930 |
142 | negative regulation of sterol transport (GO:0032372) | 3.52833930 |
143 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52043666 |
144 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51825301 |
145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51825301 |
146 | alditol metabolic process (GO:0019400) | 3.51440223 |
147 | response to nitrosative stress (GO:0051409) | 3.50932602 |
148 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.50913581 |
149 | sterol homeostasis (GO:0055092) | 3.47936313 |
150 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.45993364 |
151 | carnitine shuttle (GO:0006853) | 3.45825222 |
152 | triglyceride metabolic process (GO:0006641) | 3.45690582 |
153 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.45621741 |
154 | cytolysis (GO:0019835) | 3.44248899 |
155 | plasma lipoprotein particle organization (GO:0071827) | 3.43812151 |
156 | thioester biosynthetic process (GO:0035384) | 3.43446020 |
157 | acyl-CoA biosynthetic process (GO:0071616) | 3.43446020 |
158 | polyol transport (GO:0015791) | 3.42396422 |
159 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.42264737 |
160 | cellular response to gonadotropin stimulus (GO:0071371) | 3.41638114 |
161 | positive regulation of cholesterol transport (GO:0032376) | 3.41152912 |
162 | positive regulation of sterol transport (GO:0032373) | 3.41152912 |
163 | regulation of lipid storage (GO:0010883) | 3.36945169 |
164 | response to vitamin E (GO:0033197) | 3.34848701 |
165 | response to dietary excess (GO:0002021) | 3.29439561 |
166 | response to hydroperoxide (GO:0033194) | 3.27682704 |
167 | L-serine transport (GO:0015825) | 3.25402363 |
168 | hormone biosynthetic process (GO:0042446) | 3.24130651 |
169 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.22043665 |
170 | linoleic acid metabolic process (GO:0043651) | 3.17467675 |
171 | peroxisome fission (GO:0016559) | 3.15286993 |
172 | negative regulation of metanephros development (GO:0072217) | 3.13520829 |
173 | estrogen metabolic process (GO:0008210) | 3.11380941 |
174 | doxorubicin metabolic process (GO:0044598) | 3.07328745 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.43105871 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.49646720 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.48588086 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94198023 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.71404339 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.65465005 |
7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.36720470 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.74456709 |
9 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.31536821 |
10 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.08889388 |
11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78575026 |
12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.31124845 |
13 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.73980669 |
14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.67255210 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01820425 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5290797 |
17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93177442 |
18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.90245595 |
19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.82541040 |
20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61876183 |
21 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54065175 |
22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.50374291 |
23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.45236305 |
24 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45197230 |
25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37324854 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35920698 |
27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29422288 |
28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26765474 |
29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26346682 |
30 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24018538 |
31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.21957064 |
32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.20480234 |
33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20463240 |
34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17218947 |
35 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.11316071 |
36 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.10910962 |
37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08814304 |
38 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07703587 |
39 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.07603641 |
40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06051249 |
41 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98145508 |
42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95293030 |
43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92503932 |
44 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92146702 |
45 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90489394 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90462356 |
47 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90069860 |
48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89641068 |
49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86921582 |
50 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86588658 |
51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85778097 |
52 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83188593 |
53 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.82370652 |
54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82297701 |
55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80721595 |
56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80693526 |
57 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.79935131 |
58 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.79465698 |
59 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79343988 |
60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.79277796 |
61 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.78890080 |
62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78844994 |
63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78091059 |
64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77689693 |
65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77520464 |
66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77149803 |
67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76905515 |
68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.76358138 |
69 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.74799662 |
70 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.74602384 |
71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73948317 |
72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73657084 |
73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72579550 |
74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72579550 |
75 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.72319680 |
76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.68640081 |
77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68484816 |
78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.68283888 |
79 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.67905911 |
80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67214303 |
81 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67193232 |
82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67010547 |
83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66617636 |
84 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.66503671 |
85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.66455506 |
86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.65434672 |
87 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.65434672 |
88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64952247 |
89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.64332126 |
90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.63603985 |
91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.63603985 |
92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.63109047 |
93 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.60611176 |
94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60534346 |
95 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.60309993 |
96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59634641 |
97 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.59402086 |
98 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.59007469 |
99 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58065633 |
100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.57316295 |
101 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.57268824 |
102 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.57065679 |
103 | AR_25329375_ChIP-Seq_VCAP_Human | 0.56312222 |
104 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.56196062 |
105 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.56011968 |
106 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.55704685 |
107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55356093 |
108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.54853596 |
109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.54678190 |
110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54101025 |
111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.54033584 |
112 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.53549107 |
113 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.53529053 |
114 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53280079 |
115 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.53145336 |
116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.52977297 |
117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52771803 |
118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.52664793 |
119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52001978 |
120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51320653 |
121 | P300_19829295_ChIP-Seq_ESCs_Human | 0.51255578 |
122 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.50609849 |
123 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.50605912 |
124 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.50605912 |
125 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.50605912 |
126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50345965 |
127 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.49881159 |
128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48937414 |
129 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.48857503 |
130 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.48662958 |
131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.48525543 |
132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.47873430 |
133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47503586 |
134 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47218011 |
135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.45540463 |
136 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.45532737 |
137 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.45448223 |
138 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45410131 |
139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44659316 |
140 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.43223334 |
141 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.42246838 |
142 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.42054945 |
143 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.41226693 |
144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.41073040 |
145 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40311169 |
146 | CBP_21632823_ChIP-Seq_H3396_Human | 0.40078830 |
147 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.38224107 |
148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38130104 |
149 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37702851 |
150 | ATF3_27146783_Chip-Seq_COLON_Human | 0.37690495 |
151 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.36517503 |
152 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36509199 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.15133525 |
2 | MP0005360_urolithiasis | 6.18133450 |
3 | MP0005365_abnormal_bile_salt | 5.58889037 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.14624502 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.15656305 |
6 | MP0010329_abnormal_lipoprotein_level | 4.00434989 |
7 | MP0005670_abnormal_white_adipose | 3.55339272 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.32566855 |
9 | MP0003252_abnormal_bile_duct | 3.11990634 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.77275341 |
11 | MP0009840_abnormal_foam_cell | 2.73346970 |
12 | MP0004130_abnormal_muscle_cell | 2.56336857 |
13 | MP0003195_calcinosis | 2.54378198 |
14 | MP0005332_abnormal_amino_acid | 2.51234369 |
15 | MP0002118_abnormal_lipid_homeostasis | 2.50140224 |
16 | MP0005666_abnormal_adipose_tissue | 2.45075691 |
17 | MP0000609_abnormal_liver_physiology | 2.31718690 |
18 | MP0005083_abnormal_biliary_tract | 2.18517609 |
19 | MP0004185_abnormal_adipocyte_glucose | 2.09592893 |
20 | MP0001666_abnormal_nutrient_absorption | 2.02147888 |
21 | MP0005319_abnormal_enzyme/_coenzyme | 1.92680551 |
22 | MP0003186_abnormal_redox_activity | 1.87007656 |
23 | MP0002971_abnormal_brown_adipose | 1.78213462 |
24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71848368 |
25 | MP0004019_abnormal_vitamin_homeostasis | 1.69628362 |
26 | MP0002837_dystrophic_cardiac_calcinosis | 1.61575666 |
27 | MP0001764_abnormal_homeostasis | 1.61279407 |
28 | MP0005375_adipose_tissue_phenotype | 1.59758959 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.57371039 |
30 | MP0003828_pulmonary_edema | 1.54021720 |
31 | MP0003950_abnormal_plasma_membrane | 1.49484876 |
32 | MP0005334_abnormal_fat_pad | 1.49014214 |
33 | MP0003941_abnormal_skin_development | 1.48715155 |
34 | MP0003011_delayed_dark_adaptation | 1.46458601 |
35 | MP0002876_abnormal_thyroid_physiology | 1.41224116 |
36 | MP0005379_endocrine/exocrine_gland_phen | 1.40330495 |
37 | MP0006036_abnormal_mitochondrial_physio | 1.30304595 |
38 | MP0005647_abnormal_sex_gland | 1.29845053 |
39 | MP0009780_abnormal_chondrocyte_physiolo | 1.29398279 |
40 | MP0005535_abnormal_body_temperature | 1.28805440 |
41 | MP0009643_abnormal_urine_homeostasis | 1.28736876 |
42 | MP0002638_abnormal_pupillary_reflex | 1.27031532 |
43 | MP0001661_extended_life_span | 1.26582588 |
44 | MP0002138_abnormal_hepatobiliary_system | 1.26463671 |
45 | MP0009115_abnormal_fat_cell | 1.26130491 |
46 | MP0003656_abnormal_erythrocyte_physiolo | 1.26076966 |
47 | MP0003868_abnormal_feces_composition | 1.25235324 |
48 | MP0008438_abnormal_cutaneous_collagen | 1.23956836 |
49 | MP0005451_abnormal_body_composition | 1.17486276 |
50 | MP0000598_abnormal_liver_morphology | 1.17322264 |
51 | MP0002078_abnormal_glucose_homeostasis | 1.14525137 |
52 | MP0009697_abnormal_copulation | 1.14443672 |
53 | MP0002970_abnormal_white_adipose | 1.09430943 |
54 | MP0004272_abnormal_basement_membrane | 1.04840332 |
55 | MP0002254_reproductive_system_inflammat | 1.03393119 |
56 | MP0009763_increased_sensitivity_to | 1.02329191 |
57 | MP0005448_abnormal_energy_balance | 1.00120091 |
58 | MP0005167_abnormal_blood-brain_barrier | 0.98965864 |
59 | MP0000639_abnormal_adrenal_gland | 0.98339670 |
60 | MP0004215_abnormal_myocardial_fiber | 0.96792993 |
61 | MP0001879_abnormal_lymphatic_vessel | 0.96710517 |
62 | MP0003948_abnormal_gas_homeostasis | 0.93093827 |
63 | MP0005636_abnormal_mineral_homeostasis | 0.91633686 |
64 | MP0004782_abnormal_surfactant_physiolog | 0.90546049 |
65 | MP0000003_abnormal_adipose_tissue | 0.90052737 |
66 | MP0000604_amyloidosis | 0.88463277 |
67 | MP0003690_abnormal_glial_cell | 0.88081541 |
68 | MP0009642_abnormal_blood_homeostasis | 0.85477139 |
69 | MP0009764_decreased_sensitivity_to | 0.85366589 |
70 | MP0010368_abnormal_lymphatic_system | 0.85195537 |
71 | MP0003724_increased_susceptibility_to | 0.84285563 |
72 | MP0005376_homeostasis/metabolism_phenot | 0.83320863 |
73 | MP0001177_atelectasis | 0.81718608 |
74 | MP0001756_abnormal_urination | 0.80443186 |
75 | MP0008469_abnormal_protein_level | 0.79736989 |
76 | MP0002909_abnormal_adrenal_gland | 0.78772165 |
77 | MP0000013_abnormal_adipose_tissue | 0.77927115 |
78 | MP0008995_early_reproductive_senescence | 0.77912370 |
79 | MP0003959_abnormal_lean_body | 0.75594141 |
80 | MP0004147_increased_porphyrin_level | 0.73839962 |
81 | MP0000751_myopathy | 0.73334067 |
82 | MP0009703_decreased_birth_body | 0.70457859 |
83 | MP0001881_abnormal_mammary_gland | 0.70376703 |
84 | MP0005266_abnormal_metabolism | 0.70149081 |
85 | MP0005503_abnormal_tendon_morphology | 0.69645281 |
86 | MP0000230_abnormal_systemic_arterial | 0.69375269 |
87 | MP0006035_abnormal_mitochondrial_morpho | 0.69162838 |
88 | MP0005275_abnormal_skin_tensile | 0.68933102 |
89 | MP0003953_abnormal_hormone_level | 0.68619200 |
90 | MP0003567_abnormal_fetal_cardiomyocyte | 0.67649087 |
91 | MP0005452_abnormal_adipose_tissue | 0.67128318 |
92 | MP0008775_abnormal_heart_ventricle | 0.64572516 |
93 | MP0009765_abnormal_xenobiotic_induced | 0.64530707 |
94 | MP0006138_congestive_heart_failure | 0.64443237 |
95 | MP0002938_white_spotting | 0.64048411 |
96 | MP0005187_abnormal_penis_morphology | 0.62956503 |
97 | MP0001984_abnormal_olfaction | 0.61405951 |
98 | MP0003646_muscle_fatigue | 0.60912734 |
99 | MP0002108_abnormal_muscle_morphology | 0.60182089 |
100 | MP0002796_impaired_skin_barrier | 0.59766107 |
101 | MP0005164_abnormal_response_to | 0.59041982 |
102 | MP0002160_abnormal_reproductive_system | 0.58652811 |
103 | MP0001944_abnormal_pancreas_morphology | 0.57292148 |
104 | MP0000372_irregular_coat_pigmentation | 0.56056975 |
105 | MP0003315_abnormal_perineum_morphology | 0.54677137 |
106 | MP0001727_abnormal_embryo_implantation | 0.54074991 |
107 | MP0005330_cardiomyopathy | 0.54003072 |
108 | MP0002069_abnormal_eating/drinking_beha | 0.53865549 |
109 | MP0000749_muscle_degeneration | 0.52085188 |
110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50680845 |
111 | MP0004087_abnormal_muscle_fiber | 0.49561603 |
112 | MP0005385_cardiovascular_system_phenoty | 0.49194786 |
113 | MP0001544_abnormal_cardiovascular_syste | 0.49194786 |
114 | MP0002060_abnormal_skin_morphology | 0.49146840 |
115 | MP0009672_abnormal_birth_weight | 0.48747671 |
116 | MP0002168_other_aberrant_phenotype | 0.48404150 |
117 | MP0006276_abnormal_autonomic_nervous | 0.47875867 |
118 | MP0000343_altered_response_to | 0.47775030 |
119 | MP0004883_abnormal_blood_vessel | 0.47606464 |
120 | MP0000767_abnormal_smooth_muscle | 0.47600337 |
121 | MP0000249_abnormal_blood_vessel | 0.46877113 |
122 | MP0009053_abnormal_anal_canal | 0.46817425 |
123 | MP0005084_abnormal_gallbladder_morpholo | 0.46689158 |
124 | MP0005395_other_phenotype | 0.46290855 |
125 | MP0002136_abnormal_kidney_physiology | 0.45707859 |
126 | MP0008872_abnormal_physiological_respon | 0.43907493 |
127 | MP0003279_aneurysm | 0.42925477 |
128 | MP0000759_abnormal_skeletal_muscle | 0.42879317 |
129 | MP0003329_amyloid_beta_deposits | 0.42633205 |
130 | MP0005408_hypopigmentation | 0.41766044 |
131 | MP0001501_abnormal_sleep_pattern | 0.41677867 |
132 | MP0005220_abnormal_exocrine_pancreas | 0.39794668 |
133 | MP0001853_heart_inflammation | 0.39235147 |
134 | MP0005595_abnormal_vascular_smooth | 0.39026168 |
135 | MP0002269_muscular_atrophy | 0.38802702 |
136 | MP0002332_abnormal_exercise_endurance | 0.37837293 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.07105402 |
2 | Xanthomatosis (HP:0000991) | 6.03861863 |
3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.91484435 |
4 | Intrahepatic cholestasis (HP:0001406) | 5.79582826 |
5 | Hyperlipoproteinemia (HP:0010980) | 5.64348387 |
6 | Complement deficiency (HP:0004431) | 5.57039597 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.16579922 |
8 | Hypobetalipoproteinemia (HP:0003563) | 5.15453344 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 5.09289277 |
10 | Increased serum pyruvate (HP:0003542) | 4.99697895 |
11 | Hyperglycinuria (HP:0003108) | 4.96013904 |
12 | Epidermoid cyst (HP:0200040) | 4.90729612 |
13 | Renal salt wasting (HP:0000127) | 4.78395577 |
14 | Hyperammonemia (HP:0001987) | 4.68665920 |
15 | Abnormality of glycine metabolism (HP:0010895) | 4.66174566 |
16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.66174566 |
17 | Hypoglycemic coma (HP:0001325) | 4.57371050 |
18 | Hyperglycinemia (HP:0002154) | 4.53015124 |
19 | Hypolipoproteinemia (HP:0010981) | 4.47553058 |
20 | Hypoalphalipoproteinemia (HP:0003233) | 4.44020917 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.42700017 |
22 | Ketosis (HP:0001946) | 4.42482508 |
23 | Abnormal sex determination (HP:0012244) | 4.34435592 |
24 | Sex reversal (HP:0012245) | 4.34435592 |
25 | Abnormality of glycolysis (HP:0004366) | 4.27396948 |
26 | Reduced antithrombin III activity (HP:0001976) | 4.14792561 |
27 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.09955068 |
28 | Abnormality of complement system (HP:0005339) | 4.00621913 |
29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.82833394 |
30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.81624161 |
31 | Abnormality of alanine metabolism (HP:0010916) | 3.75980540 |
32 | Hyperalaninemia (HP:0003348) | 3.75980540 |
33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.75980540 |
34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.74035060 |
35 | Joint hemorrhage (HP:0005261) | 3.72452635 |
36 | Hypercholesterolemia (HP:0003124) | 3.54288501 |
37 | Ketoacidosis (HP:0001993) | 3.50643882 |
38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.44969498 |
39 | Growth hormone excess (HP:0000845) | 3.36845746 |
40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.33914510 |
41 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.32804978 |
42 | Abnormality of methionine metabolism (HP:0010901) | 3.31752322 |
43 | Dicarboxylic aciduria (HP:0003215) | 3.25250841 |
44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.25250841 |
45 | Fat malabsorption (HP:0002630) | 3.22782219 |
46 | Myocardial infarction (HP:0001658) | 3.20091219 |
47 | Skin nodule (HP:0200036) | 3.18459134 |
48 | Abnormality of the intrinsic pathway (HP:0010989) | 3.16138700 |
49 | Clitoromegaly (HP:0000057) | 3.15885391 |
50 | Abnormality of serum amino acid levels (HP:0003112) | 3.14179754 |
51 | Hypertriglyceridemia (HP:0002155) | 3.09855123 |
52 | Tetraparesis (HP:0002273) | 2.96842821 |
53 | Oligomenorrhea (HP:0000876) | 2.89467094 |
54 | Hyperpituitarism (HP:0010514) | 2.86511732 |
55 | Hyperbilirubinemia (HP:0002904) | 2.84823135 |
56 | Nausea (HP:0002018) | 2.84013799 |
57 | Metabolic acidosis (HP:0001942) | 2.83461889 |
58 | Lethargy (HP:0001254) | 2.80416295 |
59 | Potter facies (HP:0002009) | 2.78438753 |
60 | Facial shape deformation (HP:0011334) | 2.78438753 |
61 | Cerebral edema (HP:0002181) | 2.74182194 |
62 | Polyphagia (HP:0002591) | 2.73941341 |
63 | Hepatocellular carcinoma (HP:0001402) | 2.69376572 |
64 | Abnormal gallbladder physiology (HP:0012438) | 2.69180840 |
65 | Cholecystitis (HP:0001082) | 2.69180840 |
66 | Hydroxyprolinuria (HP:0003080) | 2.66923258 |
67 | Abnormality of proline metabolism (HP:0010907) | 2.66923258 |
68 | Long foot (HP:0001833) | 2.65672260 |
69 | Difficulty running (HP:0009046) | 2.63314811 |
70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.62543786 |
71 | Systemic lupus erythematosus (HP:0002725) | 2.61722271 |
72 | Delayed CNS myelination (HP:0002188) | 2.59356926 |
73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.59350478 |
74 | Bone cyst (HP:0012062) | 2.59169002 |
75 | Abnormal cartilage morphology (HP:0002763) | 2.58459640 |
76 | Abnormality of purine metabolism (HP:0004352) | 2.57753824 |
77 | Cholelithiasis (HP:0001081) | 2.55569012 |
78 | Abnormal gallbladder morphology (HP:0012437) | 2.55358597 |
79 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54830499 |
80 | Generalized aminoaciduria (HP:0002909) | 2.52928834 |
81 | Accelerated skeletal maturation (HP:0005616) | 2.50176336 |
82 | Spontaneous abortion (HP:0005268) | 2.49642666 |
83 | Conjugated hyperbilirubinemia (HP:0002908) | 2.47522529 |
84 | Acanthosis nigricans (HP:0000956) | 2.45851864 |
85 | Myoglobinuria (HP:0002913) | 2.45592064 |
86 | Hepatocellular necrosis (HP:0001404) | 2.45234549 |
87 | Pancreatitis (HP:0001733) | 2.45075298 |
88 | Neonatal onset (HP:0003623) | 2.44292617 |
89 | Abnormal hemoglobin (HP:0011902) | 2.43433727 |
90 | Steatorrhea (HP:0002570) | 2.43221645 |
91 | Hyperaldosteronism (HP:0000859) | 2.42919528 |
92 | Vomiting (HP:0002013) | 2.40336815 |
93 | Hypoglycemic seizures (HP:0002173) | 2.38658152 |
94 | Enlarged penis (HP:0000040) | 2.37487775 |
95 | Hypochromic microcytic anemia (HP:0004840) | 2.36493104 |
96 | CNS demyelination (HP:0007305) | 2.35886283 |
97 | Subcapsular cataract (HP:0000523) | 2.33590712 |
98 | Hemorrhage of the eye (HP:0011885) | 2.30881864 |
99 | Ileus (HP:0002595) | 2.29869243 |
100 | Brushfield spots (HP:0001088) | 2.29763079 |
101 | Acanthocytosis (HP:0001927) | 2.25909032 |
102 | Testicular atrophy (HP:0000029) | 2.24744917 |
103 | Amyloidosis (HP:0011034) | 2.22873577 |
104 | Renal cortical cysts (HP:0000803) | 2.22391792 |
105 | Acute encephalopathy (HP:0006846) | 2.21781269 |
106 | Acute necrotizing encephalopathy (HP:0006965) | 2.14966512 |
107 | Secondary amenorrhea (HP:0000869) | 2.11973572 |
108 | Abnormality of the clitoris (HP:0000056) | 2.11764070 |
109 | Hyperglycemia (HP:0003074) | 2.11751311 |
110 | Abnormal eating behavior (HP:0100738) | 2.11478430 |
111 | Renal Fanconi syndrome (HP:0001994) | 2.10932963 |
112 | Multiple enchondromatosis (HP:0005701) | 2.10635871 |
113 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.10416036 |
114 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.10416036 |
115 | Spastic diplegia (HP:0001264) | 2.06348370 |
116 | Prominent supraorbital ridges (HP:0000336) | 2.05935492 |
117 | Rhabdomyolysis (HP:0003201) | 2.05659192 |
118 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.03697436 |
119 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.03697436 |
120 | Abnormal protein glycosylation (HP:0012346) | 2.03697436 |
121 | Abnormal glycosylation (HP:0012345) | 2.03697436 |
122 | 3-Methylglutaconic aciduria (HP:0003535) | 2.03456683 |
123 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.02336929 |
124 | Abnormality of the gallbladder (HP:0005264) | 2.02022294 |
125 | Irritability (HP:0000737) | 1.99890693 |
126 | Sensorimotor neuropathy (HP:0007141) | 1.99768546 |
127 | Increased muscle lipid content (HP:0009058) | 1.99545460 |
128 | Proximal tubulopathy (HP:0000114) | 1.98883293 |
129 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.98022786 |
130 | Lactic acidosis (HP:0003128) | 1.97359982 |
131 | Mitochondrial inheritance (HP:0001427) | 1.97142039 |
132 | Esophageal varix (HP:0002040) | 1.96682796 |
133 | Late onset (HP:0003584) | 1.96304715 |
134 | Pigmentary retinal degeneration (HP:0001146) | 1.95871496 |
135 | Bifid tongue (HP:0010297) | 1.95488479 |
136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94677545 |
137 | Protrusio acetabuli (HP:0003179) | 1.93973184 |
138 | Vertebral compression fractures (HP:0002953) | 1.92920296 |
139 | Glomerulonephritis (HP:0000099) | 1.92426875 |
140 | Bicornuate uterus (HP:0000813) | 1.92225144 |
141 | Increased CSF lactate (HP:0002490) | 1.91944421 |
142 | Facial hemangioma (HP:0000329) | 1.91631308 |
143 | Insulin resistance (HP:0000855) | 1.91277976 |
144 | Adrenal overactivity (HP:0002717) | 1.90769414 |
145 | Hepatic necrosis (HP:0002605) | 1.88734482 |
146 | Progressive macrocephaly (HP:0004481) | 1.86314697 |
147 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.85901201 |
148 | Elevated hepatic transaminases (HP:0002910) | 1.85599032 |
149 | Vascular calcification (HP:0004934) | 1.85385232 |
150 | Impulsivity (HP:0100710) | 1.85160697 |
151 | Enlarged kidneys (HP:0000105) | 1.83831408 |
152 | Mitral stenosis (HP:0001718) | 1.80738091 |
153 | Hypokalemic alkalosis (HP:0001949) | 1.80687014 |
154 | Metaphyseal dysplasia (HP:0100255) | 1.80332037 |
155 | Infantile muscular hypotonia (HP:0008947) | 1.79836636 |
156 | Gout (HP:0001997) | 1.77629598 |
157 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77025138 |
158 | Malnutrition (HP:0004395) | 1.76401281 |
159 | Poikilocytosis (HP:0004447) | 1.76317677 |
160 | Thrombophlebitis (HP:0004418) | 1.75517030 |
161 | Opisthotonus (HP:0002179) | 1.75057479 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.86619445 |
2 | SIK1 | 4.65657127 |
3 | ERN1 | 4.18142983 |
4 | TRIB3 | 4.05201095 |
5 | CAMK1D | 3.49212909 |
6 | FGFR4 | 3.19699860 |
7 | EIF2AK3 | 2.57547714 |
8 | INSRR | 2.45551473 |
9 | CAMK1 | 2.43876568 |
10 | TSSK6 | 2.42784882 |
11 | MST1R | 2.31619556 |
12 | CAMK1G | 2.27868501 |
13 | PKN2 | 2.15117496 |
14 | GRK5 | 1.98687504 |
15 | PDK3 | 1.93979651 |
16 | PDK4 | 1.93979651 |
17 | LATS1 | 1.88351816 |
18 | NLK | 1.82691734 |
19 | ERBB4 | 1.78622198 |
20 | PRKAA2 | 1.73829324 |
21 | TAOK3 | 1.68337295 |
22 | NEK9 | 1.66547432 |
23 | MAPK11 | 1.59422527 |
24 | GRK1 | 1.48487732 |
25 | MAP2K4 | 1.47273094 |
26 | RIPK1 | 1.47039045 |
27 | FLT3 | 1.45340440 |
28 | FRK | 1.34256683 |
29 | TESK1 | 1.32287121 |
30 | FGFR2 | 1.31420514 |
31 | PIK3CG | 1.30986075 |
32 | ABL2 | 1.28547612 |
33 | DAPK3 | 1.27689825 |
34 | STK16 | 1.25834151 |
35 | DDR2 | 1.20069562 |
36 | BMPR1B | 1.17660944 |
37 | PDK2 | 1.16672943 |
38 | TYK2 | 1.11293141 |
39 | JAK2 | 1.08083195 |
40 | DAPK2 | 1.06427773 |
41 | PINK1 | 1.04368050 |
42 | EIF2AK1 | 1.02967245 |
43 | TIE1 | 1.02877925 |
44 | CDK6 | 1.00581858 |
45 | EPHB2 | 0.99937638 |
46 | JAK1 | 0.99429866 |
47 | NEK1 | 0.98882174 |
48 | MAP2K1 | 0.98696128 |
49 | STK38L | 0.98083607 |
50 | ILK | 0.96413169 |
51 | ADRBK1 | 0.94596782 |
52 | PRKAA1 | 0.94125348 |
53 | MET | 0.91429885 |
54 | PTK6 | 0.90162678 |
55 | FGFR3 | 0.90153984 |
56 | KDR | 0.89008360 |
57 | MAP3K3 | 0.88539966 |
58 | PIK3CA | 0.88143140 |
59 | MAP2K3 | 0.87995969 |
60 | TGFBR2 | 0.87295216 |
61 | NUAK1 | 0.86783635 |
62 | MAP3K6 | 0.85617485 |
63 | KIT | 0.85316888 |
64 | VRK2 | 0.82533818 |
65 | WNK3 | 0.81539298 |
66 | ZAK | 0.81095596 |
67 | PRKACG | 0.80580042 |
68 | CDK9 | 0.80257856 |
69 | PAK2 | 0.78196799 |
70 | MAPK12 | 0.75820039 |
71 | IRAK3 | 0.75814836 |
72 | MKNK1 | 0.75189964 |
73 | PDPK1 | 0.75165696 |
74 | TNIK | 0.75138067 |
75 | EIF2AK2 | 0.74974225 |
76 | CSNK1G1 | 0.71941563 |
77 | LATS2 | 0.71727904 |
78 | GSK3A | 0.70430053 |
79 | PBK | 0.70392557 |
80 | AKT2 | 0.68915493 |
81 | LMTK2 | 0.68415106 |
82 | MYLK | 0.67945916 |
83 | PRKG1 | 0.67214083 |
84 | TBK1 | 0.66967337 |
85 | TAF1 | 0.66925412 |
86 | PDGFRA | 0.65297952 |
87 | DYRK3 | 0.64962768 |
88 | PIM2 | 0.64635548 |
89 | MKNK2 | 0.64342944 |
90 | MAP3K7 | 0.63812559 |
91 | ACVR1B | 0.62808273 |
92 | CDK3 | 0.62708612 |
93 | MAPKAPK5 | 0.62565868 |
94 | CDK4 | 0.61860311 |
95 | MTOR | 0.60416138 |
96 | MAPK4 | 0.59062061 |
97 | PRKCZ | 0.57703202 |
98 | IGF1R | 0.57557198 |
99 | MAP3K13 | 0.56928764 |
100 | STK3 | 0.55090890 |
101 | YES1 | 0.53670623 |
102 | SCYL2 | 0.52392849 |
103 | DAPK1 | 0.51165181 |
104 | CLK1 | 0.50888720 |
105 | PDK1 | 0.50046097 |
106 | TEC | 0.49701997 |
107 | MAP3K11 | 0.48591790 |
108 | PRKCH | 0.46184659 |
109 | SRPK1 | 0.46057352 |
110 | MAP4K2 | 0.46013009 |
111 | AKT3 | 0.45501855 |
112 | MARK3 | 0.45199062 |
113 | KSR2 | 0.45125983 |
114 | RET | 0.45016260 |
115 | PLK3 | 0.44834146 |
116 | OBSCN | 0.44810288 |
117 | TGFBR1 | 0.42148659 |
118 | PRKACB | 0.41439897 |
119 | EPHA3 | 0.39484890 |
120 | RPS6KA3 | 0.38738420 |
121 | ERBB2 | 0.38727450 |
122 | RPS6KA5 | 0.38317860 |
123 | SGK3 | 0.37782049 |
124 | PRKD1 | 0.37256292 |
125 | CAMK2G | 0.37060811 |
126 | CSNK2A1 | 0.35811111 |
127 | MAP3K4 | 0.35574887 |
128 | PLK4 | 0.35164841 |
129 | EPHB1 | 0.34043288 |
130 | DYRK1B | 0.33191989 |
131 | MAP3K10 | 0.30368930 |
132 | MAP3K5 | 0.30263840 |
133 | BMX | 0.29159441 |
134 | FER | 0.28480654 |
135 | FGFR1 | 0.27304193 |
136 | ICK | 0.26119568 |
137 | CSF1R | 0.25797332 |
138 | CSK | 0.25589220 |
139 | MAPK3 | 0.23934883 |
140 | IRAK1 | 0.23442706 |
141 | MAPK7 | 0.22391311 |
142 | JAK3 | 0.22315379 |
143 | GRK6 | 0.22158579 |
144 | PTK2 | 0.20848239 |
145 | ABL1 | 0.20173818 |
146 | INSR | 0.20161616 |
147 | NME2 | 0.19874186 |
148 | PTK2B | 0.19463582 |
149 | IKBKE | 0.18907491 |
150 | IRAK2 | 0.18144881 |
151 | PRKACA | 0.17164016 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.82843664 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.17945092 |
3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.97241098 |
4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.93084008 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.92040052 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78745391 |
7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.75014524 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74146854 |
9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.63676713 |
10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.59620873 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59431018 |
12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.53213629 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45327174 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36356691 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25429459 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.19993244 |
17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.18508002 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11904722 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91609330 |
20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88848856 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88227352 |
22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.88059688 |
23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.86145948 |
24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78022156 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71310244 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70148683 |
27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70091450 |
28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.69218983 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61882813 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60448108 |
31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59448375 |
32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.54467571 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54353855 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51841137 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45975327 |
36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44905294 |
37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42252527 |
38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.40797406 |
39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40654094 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.40606122 |
41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.37967224 |
42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24184262 |
43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.24095245 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23374412 |
45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.23123003 |
46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22875808 |
47 | Bile secretion_Homo sapiens_hsa04976 | 1.20073127 |
48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18518147 |
49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14197457 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04235346 |
51 | ABC transporters_Homo sapiens_hsa02010 | 1.00813717 |
52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99904692 |
53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95484665 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91936447 |
55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90571010 |
56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84115665 |
57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82261102 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80511473 |
59 | Proteasome_Homo sapiens_hsa03050 | 0.80404566 |
60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79262901 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.78185689 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76489537 |
63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72263269 |
64 | RNA polymerase_Homo sapiens_hsa03020 | 0.69932387 |
65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68432480 |
66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67319320 |
67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60761641 |
68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60344089 |
69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.57571209 |
70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55814752 |
71 | Ribosome_Homo sapiens_hsa03010 | 0.55660804 |
72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49613746 |
73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48692785 |
74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47947356 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.47100755 |
76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.46545063 |
77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42612023 |
78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37072263 |
79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35338930 |
80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35122181 |
81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34591947 |
82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32731109 |
83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30421720 |
84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29484629 |
85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29399255 |
86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.29197530 |
87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26795377 |
88 | Prion diseases_Homo sapiens_hsa05020 | 0.25893815 |
89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23762483 |
90 | Renin secretion_Homo sapiens_hsa04924 | 0.20718051 |
91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18710074 |
92 | Protein export_Homo sapiens_hsa03060 | 0.17756112 |
93 | Purine metabolism_Homo sapiens_hsa00230 | 0.14810364 |
94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11043116 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03839953 |
96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.02600708 |
97 | Basal transcription factors_Homo sapiens_hsa03022 | 0.01901688 |
98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.01173343 |
99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2245761 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2237560 |
101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2119448 |
102 | Amoebiasis_Homo sapiens_hsa05146 | -0.2063273 |
103 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2000133 |
104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1971382 |
105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1893365 |
106 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1654493 |
107 | Hepatitis C_Homo sapiens_hsa05160 | -0.1599905 |
108 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1527610 |
109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1516361 |
110 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1333197 |
111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1086818 |
112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0846572 |
113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.0719753 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0606826 |
115 | Base excision repair_Homo sapiens_hsa03410 | -0.0586513 |
116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0524962 |
117 | Mineral absorption_Homo sapiens_hsa04978 | -0.0457600 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0342708 |
119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.0299893 |
120 | Malaria_Homo sapiens_hsa05144 | -0.0092551 |